Charis Industries Co. (dba Red Mountain Pharmaceuticals Inc.) (RMPI) (PINKSHEETS: RMPI) has merged with Zalemark Inc. Zalemark (www.zalemark.com) is a leading jewelry branding, design, and manufacturing company headquartered in Sherman Oaks, California. Terms of the merger were not disclosed. The surviving company will soon be renamed Zalemark Holding Company Inc., and application made for a new ticker symbol.

Steven Zale (founder of Zalemark Inc. and an award winning jewelry designer with over 25 years experience in the jewelry industry) the new Chairman and CEO remarked, "This merger, along with a very talented management team, is a key component for growth, both organically and strategically. In good and bad economies, well-known brands help drive traffic to retailers -- traditional, online and television. The entire Zalemark team is excited about this merger and the opportunities it provides to leverage on our unique position in the industry. Our focus will be on our commitment to drive revenue and profitability, and to build value for the benefit of our shareholders."

Duane Roberts, former Chairman and CEO of RMPI adds, "Zalemark has made the transition from a development stage company to an actual revenue producing company. Over my twenty-year career, my best investments with the greatest returns came from owning equity in companies that were making such of a transition. Zalemark has a great management team that knows how to run a business, growing demand for their products and phenomenal growth potential. This merger will create wealth for all of the RMPI shareholders. I am very excited to have completed this merger."

Zalemark designs, develops, manufactures, and markets world-class lines of branded jewelry. The Company's current brand properties include Seventeen(TM), ESQ(TM), Badgley Mischka (TM), B. Smith(TM), Demeter (R), and several celebrity brands. Additional nationally recognized brands are currently under development.

For more information contact: Duane Roberts 214-987-0844 Investor Relations

http://www.bloomberg.com/apps/news?pid=conewsstory&refer=conews&tkr=RMPI%3AUS&sid=acu7mpTxPvlk